Details of the Drug Reposition

General Information of This Drug (ID: DM26VCZ)

Drug Name
Anti-NY-ESO-1 CAR-T cells   DM26VCZ
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple myeloma DISEWP9B 2A83 Phase 1/2 [1]
Synovial sarcoma DISEZJS7 2B5A Phase 1/2 [1]
Esophageal cancer DISGB2VN 2B70 Phase 1/2 [1]
Lung cancer DISCM4YA 2C25.0 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies